Literature DB >> 17686504

Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling.

Grégory Caignard1, Mathilde Guerbois, Jean-Louis Labernardière, Yves Jacob, Louis M Jones, Fabian Wild, Frédéric Tangy, Pierre-Olivier Vidalain.   

Abstract

Viruses have evolved various strategies to escape the antiviral activity of type I interferons (IFN-alpha/beta). For measles virus, this function is carried by the polycistronic gene P that encodes, by an unusual editing strategy, for the phosphoprotein P and the virulence factor V (MV-V). MV-V prevents STAT1 nuclear translocation by either sequestration or phosphorylation inhibition, thereby blocking IFN-alpha/beta pathway. We show that both the N- and C-terminal domains of MV-V (PNT and VCT) contribute to the inhibition of IFN-alpha/beta signaling. Using the two-hybrid system and co-affinity purification experiments, we identified STAT1 and Jak1 as interactors of MV-V and demonstrate that MV-V can block the direct phosphorylation of STAT1 by Jak1. A deleterious mutation within the PNT domain of MV-V (Y110H) impaired its ability to interact and block STAT1 phosphorylation. Thus, MV-V interacts with at least two components of IFN-alpha/beta receptor complex to block downstream signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686504     DOI: 10.1016/j.virol.2007.06.037

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  71 in total

1.  Measles virus C protein interferes with Beta interferon transcription in the nucleus.

Authors:  Konstantin M J Sparrer; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity.

Authors:  Kerstin M Schuhmann; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 4.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

5.  Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Neelam Dhiman; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  J Med Virol       Date:  2010-11       Impact factor: 2.327

6.  Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice.

Authors:  Makoto Takeda; Shinji Ohno; Maino Tahara; Hiroki Takeuchi; Yuta Shirogane; Hirofumi Ohmura; Takafumi Nakamura; Yusuke Yanagi
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

Review 7.  Paramyxovirus disruption of interferon signal transduction: STATus report.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

8.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism.

Authors:  Michael J Ciancanelli; Valentina A Volchkova; Megan L Shaw; Viktor E Volchkov; Christopher F Basler
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.